Login / Signup

Pharmacokinetics Profiler (PhaKinPro): Model Development, Validation, and Implementation as a Web Tool for Triaging Compounds with Undesired Pharmacokinetics Profiles.

Marielle RathJames WellnitzHolli-Joi SullivanCleber Melo-FilhoJoshua E HochuliGuilherme Martins SilvaJon-Michael BeasleyMaxfield TravisZoe L SessionsKonstantin I PopovAlexey V ZakharovArtem CherkasovVinicius AlvesEugene N MuratovAlexander Trospsha
Published in: Journal of medicinal chemistry (2024)
Computational models that predict pharmacokinetic properties are critical to deprioritize drug candidates that emerge as hits in high-throughput screening campaigns. We collected, curated, and integrated a database of compounds tested in 12 major end points comprising over 10,000 unique molecules. We then employed these data to build and validate binary quantitative structure-activity relationship (QSAR) models. All trained models achieved a correct classification rate above 0.60 and a positive predictive value above 0.50. To illustrate their utility in drug discovery, we used these models to predict the pharmacokinetic properties for drugs in the NCATS Inxight Drugs database. In addition, we employed the developed models to predict the pharmacokinetic properties of all compounds in the DrugBank. All models described in this paper have been integrated and made publicly available via the PhaKinPro Web-portal that can be accessed at https://phakinpro.mml.unc.edu/.
Keyphrases
  • drug discovery
  • structure activity relationship
  • healthcare
  • emergency department
  • high resolution
  • molecular dynamics
  • big data
  • mass spectrometry
  • resistance training